Status:
COMPLETED
Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)
Lead Sponsor:
Intergroupe Francophone de Cancerologie Thoracique
Conditions:
NSCLC
Eligibility:
All Genders
70-89 years
Phase:
PHASE3
Brief Summary
The last ASCO recommendations in 2003 for the treatment of a CBNPC of stage IIIB/IV of elderly people, are to manage a monochemotherapy. Paclitaxel in association with carboplatin is feasible in elder...
Detailed Description
It thus seemed to us justified to compare a standard arm, the vinorelbine or the gemcitabine (with the choice of the center) in monotherapy with an experimental arm, association carboplatine + paclita...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Pathologically / cytologically proven NSCLC stage IIIB or IV
- age \>= 70 years old and \< 90 years old
Exclusion
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
451 Patients enrolled
Trial Details
Trial ID
NCT00298415
Start Date
March 1 2006
End Date
December 1 2011
Last Update
October 25 2013
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
CH - Pneumologie
Belfort, France, 90000
2
CHU Besancon - Pneumologie
Besançon, France, 25000
3
CHU - Pneumologie
Caen, France, 14000
4
CHU
Grenoble, France